Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 5 of 5 publications.

Thase MF, Fava M, Hollander S, Simmons JH, Ivgy-May N, Boyle K, Gibertini M. Analysis of the effects of gepirone-ER on the Bech-6 and individual HAM-D 17-item scores. Poster presented at the 2003 42nd ACNP Annual Meeting; December 2003. San Juan, Puerto Rico.

Allen RM, Granger AL, Dykstra LA. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor. J Pharmacol Exp Ther. 2003 Nov 1;307(2):785-92.

Granger AL, Fehnel SE, Bell T. Humanistic and financial impacts of restless legs syndrome form the patients' perspective. Poster presented at the 7th Congress of the European Federation of Neurological Societies; August 2003.

Sapienza S, Sacco P, Floyd K, DiCesare J, Doan Q. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting. Clin Ther. 2003 Jun;25(6):1872-87.

Price MA, Fiore T, Tanner A, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—updated cross project analysis report. 2003.